Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 192
Selected: 0
NCT IDTitle
NCT01534143High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
NCT03147885Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
NCT00369109Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00238329PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
NCT00872677Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
NCT05903092MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
NCT05556473F-Tryptophan PET/CT in Human Cancers
NCT05028374COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
NCT03183050MEND 2: Making Treatment Decisions Using Genomic Testing
NCT00002585Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
NCT00066326Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
NCT00942422Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
NCT07343297Ask Questions About Clinical Trials
NCT03454529The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
NCT04237584A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients
NCT01116232Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
NCT00004144Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
NCT02472275PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
NCT03328091Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT00499694Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
NCT00258310Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
NCT00003250Fenretinide in Treating Patients With Solid Tumors
NCT00002547Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT04055649ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
NCT01147016Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
NCT07436078Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT00521261Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT02372877Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT06576115Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
NCT00559897Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00002656Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00918762Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
NCT01609816Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
NCT00305747Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
NCT03421652Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
NCT02178436Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer
NCT07222306Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
NCT01246206Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
NCT00288028Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
NCT01468532Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT02568449Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
NCT05025748Ask Questions (ASQ):Implementation of a Communication Intervention
NCT02145078Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
NCT00003171Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
NCT009350903'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT00248560Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
NCT07735819Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma
NCT00227721Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
NCT04037462Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy